References
- 1. A. J. Duncan and S. J. Heales, Nitric oxide and neurological disorders, Mol. Aspects Med. 26(1–2) (2005) 67–96; https://doi.org/10.1016/j.mam.2004.09.00415722115
- 2. R. Stojanovic, Z. Todorovic, Z. Nesic, S. Vuckovic, N. Cerovac-Cosic and M. Prostran, NG-nitro-larginine methyl ester-induced potentiaton of the effect of aminophylline on rat diaphragm: the role of extracellular calcium, J. Pharmacol. Sci. 96(4) (2004) 493–498; https://doi.org/10.1254/jphs.sce04001x15599090
- 3. K. Yamamoto, H. Takei, Y. Koyanagi, N. Koshikawa and M. Kobayashi, Presynaptic cell type-dependent regulation of GABAergic synaptic transmission by nitric oxide in rat insular cortex, Neuroscience 284 (2015) 65–77; https://doi.org/10.1016/j.neuroscience.2014.09.06225286388
- 4. L. Yassin, S. Radtke-Schuller, H. Asraf, B. Grothe, M. Hershfinkel, I. D. Forsythe and C. Kopp-Scheinpflug, Nitric oxide signaling modulates synaptic inhibition in the superior paraolivary nucleus (SPN) via cGMP-dependent suppression of KCC2, Front. Neural Circuits 8 (2014) Article ID 65 (12 pages); https://doi.org/10.3389/fncir.2014.00065406073124987336
- 5. K. M. Boje, Nitric oxide neurotoxicity in neurodegenerative diseases, Front. Biosci. 9 (2004) 763–776; https://doi.org/10.2741/126814766406
- 6. O. Akyol, S. S. Zoroglu, F. Armutcu, S. Sahin and A. Gurel, Nitric oxide as a physiopathological factor in neuropsychiatric disorders, In Vivo 18(3) (2004) 377–390.
- 7. O. Devinsky, A. Vezzani, T. J. O’Brien, N. Jette, I. E. Scheffer, M. de Curtis and P. Perucca, Epilepsy, Nat. Rev. Dis. Primers 4 (2018) Article ID 18024; https://doi.org/10.1038/nrdp.2018.2429722352
- 8. G. Ferraro and P. Sardo, Nitric oxide and brain hyperexcitability, In Vivo 18(3) (2004) 357–366.
- 9. K. Tieu, H. Ischiropoulos and S. Przedborski, Nitric oxide and reactive oxygen species in Parkinson’s disease, IUBMB Life 55(6) (2003) 329–335; https://doi.org/10.1080/152165403200011432012938735
- 10. M. Hsu, B. Srinivas, J. Kumar, R. Subramanian and J. Andersen, Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson’s disease, J. Neurochem. 92(5) (2005) 1091–1103; https://doi.org/10.1111/j.1471-4159.2004.02929.x15715660
- 11. D. Hrncic, A. Rasic-Markovic, D. Krstic, D. Macut, D. Djuric and O. Stanojlovic, The role of nitric oxide in homocysteine thiolactone-induced seizures in adult rats, Cell. Mol. Neurobiol. 30(2) (2010) 219–231; https://doi.org/10.1007/s10571-009-9444-919714460
- 12. S. H. Snyder, Janus faces of nitric oxide, Nature 364(6438) (1993) 577; https://doi.org/10.1038/364577a08102475
- 13. G. Rondouin, M. Lerner-Natoli, O. Manzoni, M. Lafon-Cazal and J. Bockaert, A nitric oxide (NO) synthase inhibitor accelerates amygdala kindling, Neuroreport 3(9) (1992) 805–808; https://doi.org/10.1097/00001756-199209000-000211384771
- 14. A. Becker, G. Grecksch and H. Schroder, Nω-nitro-l-arginine methyl ester interferes with pentylenetetrazol-induced kindling and has no effect on changes in glutamate binding, Brain Res. 688(1–2) (1995) 230–232; https://doi.org/10.1016/0006-8993(95)00565-88542315
- 15. P. Tutka, P. Klonowski, J. Dzieciuch, Z. Kleinrok and S. J. Czuczwar, NG-nitro-l-arginine differentially affects glutamate- or kainate-induced seizures, Neuroreport 7(10) (1996) 1605–1608; https://doi.org/10.1097/00001756-199607080-000158904765
- 16. E. Przegalinski, L. Baran and J. Siwanowicz, The role of nitric oxide in chemically- and electrically-induced seizures in mice, Neurosci. Lett. 217(2–3) (1996) 145–148.10.1016/0304-3940(96)13085-8
- 17. M. S. Starr and B. S. Starr, Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide? Eur. J. Pharmacol. 272(2–3) (1995) 211–217; https://doi.org/10.1016/0014-2999(94)00644-m7713165
- 18. E. M. Urbanska, E. Drelewska, K. K. Borowicz, P. Blaszczak, Z. Kleinrok and S. J. Czuczwar NG-nitro-l-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice, J. Neural Transm. (Vienna) 103(10) (1996) 1145–1152; https://doi.org/10.1007/BF012711999013401
- 19. L. A. Vega, G. Ceballos and F. Vega-Diaz, Role of nitric oxide synthase on brain GABA transaminase activity and GABA levels, Acta Pharm. 68(3) (2018) 349–359; https://doi.org/10.2478/acph-2018-002231259693
- 20. O. Devinsky, A. Vezzani, S. Najjar, N. C. De Lanerolle and M. A. Rogawski, Glia and epilepsy: excitability and inflammation, Trends Neurosci. 36(3) (2013) 174–184; https://doi.org/10.1016/j.tins.2012.11.00823298414
- 21. Y. Chen, C. Qin, J. Huang, X. Tang, C. Liu, K. Huang, J. Xu, G. Guo, A. Tong and L. Zhou, The role of astrocytes in oxidative stress of central nervous system: A mixed blessing, Cell. Prolif. 53(3) (2020) e12781; https://doi.org/10.1111/cpr.12781710695132035016
- 22. A. Falkowska, I. Gutowska, M. Goschorska, P. Nowacki, D. Chlubek and I. Baranowska-Bosiacka, Energy metabolism of the brain, including the cooperation between astrocytes and neurons, especially in the context of glycogen metabolism, Int. J. Mol. Sci. 16(11) (2015) 25959–25981; https://doi.org/10.3390/ijms161125939466179826528968
- 23. D. Boison and C. Steinhauser, Epilepsy and astrocyte energy metabolism, Glia 66(6) (2018) 1235–1243; https://doi.org/10.1002/glia.23247590395629044647
- 24. M. De Pitta, N. Brunel and A. Volterra, Astrocytes: Orchestrating synaptic plasticity?, Neuroscience 323 (2016) 43–61; https://doi.org/10.1016/j.neuroscience.2015.04.00125862587
- 25. S. M. Q. Hussaini and M. H. Jang, New roles for old glue: astrocyte function in synaptic plasticity and neurological disorders, Int. Neurourol. J. 22(Suppl. 3) (2018) S106–S114; https://doi.org/10.5213/inj.1836214.107623472830396259
- 26. A. Volterra and J. Meldolesi, Astrocytes, from brain glue to communication elements: the revolution continues, Nat. Rev. Neurosci. 6(8) (2005) 626–640; https://doi.org/10.1038/nrn172216025096
- 27. L. K. Bak, A. Schousboe and H. S. Waagepetersen, The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer, J. Neurochem. 98(3) (2006) 641–653; https://doi.org/10.1111/j.1471-4159.2006.03913.x16787421
- 28. N. N. Haj-Yasein, V. Jensen, I. Ostby, S. W. Omholt, J. Voipio, K. Kaila, O. P. Ottersen, O. Hvalby and E. A. Nagelhus, Aquaporin-4 regulates extracellular space volume dynamics during high-frequency synaptic stimulation: a gene deletion study in mouse hippocampus, Glia 60(6) (2012) 867–874; https://doi.org/10.1002/glia.2231922419561
- 29. F. Vasile, E. Dossi and N. Rouach, Human astrocytes: structure and functions in the healthy brain, Brain Struct. Funct. 222(5) (2017) 2017–2029; https://doi.org/10.1007/s00429-017-1383-5550425828280934
- 30. N. J. Abbott, L. Ronnback and E. Hansson, Astrocyte-endothelial interactions at the blood-brain barrier, Nat. Rev. Neurosci. 7(1) (2006) 41–53; https://doi.org/10.1038/nrn182416371949
- 31. Y. Serlin, I. Shelef, B. Knyazer and A. Friedman, Anatomy and physiology of the blood-brain barrier, Semin. Cell Dev. Biol. 38 (2015) 2–6; https://doi.org/10.1016/j.semcdb.2015.01.002439716625681530
- 32. G. R. Gordon, S. J. Mulligan and B. A. MacVicar, Astrocyte control of the cerebrovasculature, Glia 55(12) (2007) 1214–1221; https://doi.org/10.1002/glia.2054317659528
- 33. C. Iadecola and M. Nedergaard, Glial regulation of the cerebral microvasculature, Nat. Neurosci. 10(11) (2007) 1369–1376; https://doi.org/10.1038/nn200317965657
- 34. S. Robel and H. Sontheimer, Glia as drivers of abnormal neuronal activity, Nat. Neurosci. 19(1) (2016) 28–33; https://doi.org/10.1038/nn.4184496616026713746
- 35. A. Tabernero, J. P. Bolanos and J. M. Medina, Lipogenesis from lactate in rat neurons and astrocytes in primary culture, Biochem. J. 294(3) (1993) 635–638; https://doi.org/10.1042/bj294063511345088379917
- 36. R. F. Squires, E. Saederup, J. N. Crawley, P. Skolnick and S. M. Paul, Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain, Life Sci. 35(14) (1984) 1439–1444; https://doi.org/10.1016/0024-3205(84)90159-06090836
- 37. A. Tourov, R. Ferri, S. Del Gracco, M. Elia, S. A. Musumeci and M. C. Stefanini, Spike morphology in PTZ-induced generalized and cobalt-induced partial experimental epilepsy, Funct. Neurol. 11(5) (1996) 237–245.
- 38. N. Y. Lukomskaya, N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro and L. G. Magazanik, Studies of the roles of NMDA and AMPA glutamate receptors in the mechanism of corasole convulsions in mice, Neurosci. Behav. Physiol. 34(8) (2004) 783–789; https://doi.org/10.1023/b:neab.0000038128.02725.7e15587806
- 39. X. Zhu, J. Dong, B. Han, R. Huang, A. Zhang, Z. Xia, H. Chang, J. Chao and H. Yao, Neuronal nitric oxide synthase contributes to PTZ kindling epilepsy-induced hippocampal endoplasmic reticulum stress and oxidative damage, Front. Cell. Neurosci. 11 (2017) Article ID 377 (16 pages); https://doi.org/10.3389/fncel.2017.00377571233729234274
- 40. A. Morales-Villagran and R. Tapia, Preferential stimulation of glutamate release by 4-aminopyri-dine in rat striatum in vivo, Neurochem. Int. 28(1) (1996) 35–40; https://doi.org/10.1016/0197-0186(95)00064-f8746762
- 41. L. Medina-Ceja, A. Morales-Villagran and R. Tapia, Action of 4-aminopyridine on extracellular amino acids in hippocampus and entorhinal cortex: a dual microdialysis and electroencehalo-graphic study in awake rats, Brain Res. Bull. 53(3) (2000) 255–262; https://doi.org/10.1016/s0361-9230(00)00336-111113578
- 42. F. Pena and R. Tapia, Relationships among seizures, extracellular amino acid changes, and neuro-degeneration induced by 4-aminopyridine in rat hippocampus: a microdialysis and electroencephalographic study, J. Neurochem. 72(5) (1999) 2006–2014; https://doi.org/10.1046/j.1471-4159.1999.0722006.x10217278
- 43. F. Pena and R. Tapia, Seizures and neurodegeneration induced by 4-aminopyridine in rat hippo-campus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels, Neuroscience 101(3) (2000) 547–561; https://doi.org/10.1016/s0306-4522(00)00400-011113304
- 44. D. R. Curtis, A. W. Duggan, D. Felix and G. A. Johnston, GABA, bicuculline and central inhibition, Nature 226(5252) (1970) 1222–1224; https://doi.org/10.1038/2261222a04393081
- 45. V. Seutin and S. W. Johnson, Recent advances in the pharmacology of quaternary salts of bicucul-line, Trends Pharmacol. Sci. 20(7) (1999) 268–270; https://doi.org/10.1016/s0165-6147(99)01334-610390643
- 46. W. P. Arnold, C. K. Mittal, S. Katsuki and F. Murad, Nitric oxide activates guanylate cyclase and increases guanosine 3’:5’-cyclic monophosphate levels in various tissue preparations, Proc. Natl. Acad. Sci. USA 74(8) (1977) 3203–3207; https://doi.org/10.1073/pnas.74.8.320343149820623
- 47. J. Garthwaite, Glutamate, nitric oxide and cell-cell signalling in the nervous system, Trends Neurosci. 14(2) (1991) 60–67; https://doi.org/10.1016/0166-2236(91)90022-m1708538
- 48. J. Garthwaite, Nitric oxide signalling in the nervous system, Semin. Neurosci. 5 (1993) 171–180.10.1016/S1044-5765(05)80050-8
- 49. J. Garthwaite, S. L. Charles and R. Chess-Williams, Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain, Nature 336(6197) (1988) 385–388; https://doi.org/10.1038/336385a02904125
- 50. A. Klaassen, J. Glykys, J. Maguire, C. Labarca, I. Mody and J. Boulter, Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy, Proc. Natl. Acad. Sci. USA 103(50) (2006) 19152–19157; https://doi.org/10.1073/pnas.0608215103168135117146052
- 51. I. Cohen, V. Navarro, S. Clemenceau, M. Baulac and R. Miles, On the origin of interictal activity in human temporal lobe epilepsy in vitro, Science 298(5597) (2002) 1418–1421; https://doi.org/10.1126/science.107651012434059
- 52. F. Jensen, Developmental factors regulating susceptibility to perinatal brain injury and seizures, Curr. Opin. Pediatr. 18(6) (2006) 628–633; https://doi.org/10.1097/MOP.Ob013e328010c536
- 53. Y. Ben-Ari, C. Rovira, J.L. Gaiarsa, R. Corradetti, O. Robain and E. Cherubini, GABAergic mechanisms in the CA3 hippocampal region during early postnatal life, Prog. Brain Res. 83 (1990) 313–321; https://doi.org/10.1016/s0079-6123(08)61259-52168059
- 54. S. Zanelli, M. Naylor and J. Kapur, Nitric oxide alters GABAergic synaptic transmission in cultured hippocampal neurons, Brain Res. 1297 (2009) 23–31; https://doi.org/10.1016/j.brainres.2009.08.044279299019699726
- 55. Z. Huang, P. L. Huang, J. Ma, W. Meng, C. Ayata, M. C. Fishman, and M. A. Moskowitz, Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-l-arginine, J. Cereb. Blood Flow Metab. 16(5) (1996) 981–987; https://doi.org/10.1097/00004647-199609000-000238784243
- 56. E. Morikawa, M. A. Moskowitz, Z. Huang, T. Yoshida, K. Irikura and T. Dalkara, l-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat, Stroke 25(2) (1994) 429–435; https://doi.org/10.1161/01.str.25.2.4297508154
- 57. M. Endres, U. Laufs, Z. Huang, T. Nakamura, P. Huang, M. A. Moskowitz and J. K. Liao, Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reducta se inhibitors mediated by endothelial nitric oxide synthase, Proc. Natl. Acad. Sci. USA 95(15) (1998) 8880–8885; https://doi.org/10.1073/pnas.95.15.8880211719671773
- 58. K. Iwase, K. Miyanaka, A. Shimizu, A. Nagasaki, T. Gotoh, M. Mori and M. Takiguchi, Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment, J. Biol. Chem. 275(16) (2000) 11929–11933; https://doi.org/10.1074/jbc.275.16.1192910766821
- 59. J. L. Dinerman, T. M. Dawson, M. J. Schell, A. Snowman and S. H. Snyder, Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity, Proc. Natl. Acad. Sci. USA 91(10) (1994) 4214–4218; https://doi.org/10.1073/pnas.91.10.4214437557514300
- 60. A. Caviedes, M. Varas-Godoy, C. Lafourcade, S. Sandoval, J. Bravo-Alegria, T. Kaehne, A. Mass-mann, J. P. Figueroa, F. Nualart and U. Wyneken, Endothelial nitric oxide synthase is present in dendritic spines of neurons in primary cultures, Front. Cell. Neurosci. 11 (2017) Article ID 180; https://doi.org/10.3389/fncel.2017.00180549583128725180